Woodline Partners’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.13M	Hold	301,612	–	–	0.01%	794
2025 Q1	$832K	Sell	301,612 -10,000	-3%	-$27.6K	0.01%	784
2024 Q4	$1.73M	Buy	311,612 +10,388	+3%	+$57.5K	0.01%	676
2024 Q3	$2.51M	Sell	301,224 -443,820	-60%	-$3.7M	0.02%	451
2024 Q2	$5.07M	Buy	+745,044	New	+$5.07M	0.05%	335